Oseltamivir

NATCO launched the 1st generic version of Oseltamivir Capsules – in the United States in collaboration with our marketing partner, Alvogen during the flu season in December 2016. NATCO, being the only generic player during this flu season, makes this launch a notable blockbuster!

The successful execution of such a blockbuster product also highlights the inherent strength of
our processes, quality systems and capabilities of our team.

Oseltamivir is indicated for the treatment of acute, uncomplicated influenza. NATCO product is available in all the three strengths of 30mg, 45mg & 75mg.